Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 1

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 3
Chunk 1
---
ITEM
3. KEY INFORMATION

3. A.1.
[Reserved]

3. B.
Capitalization and Indebtedness

Not
applicable.

3. C.
Reasons for the Offer and Use of Proceeds

Not
applicable.

   4  

3. D.
Risk Factors

Risks
pertaining to the Company:

The
Company’s limited operating history makes it difficult to evaluate the Company’s current business and forecast future results.

Since
its inception, the Company has had limited revenues and has experienced significant operating losses each year. These losses are due
to substantial expenditures on intellectual property protection, product development and product testing of commercial and consumer infection
control product and pre-clinical testing for registration of a number of therapeutic products and over-the-counter (OTC) pharmaceutical
products with Health Canada and the FDA. Sales of T 3 ®

The
Company has commenced generating operating cash flow, however failure to generate sufficient revenues and cash flow in the future could
cause the Company to go out of business.

The
Company has no history of pre-tax profit and in the previous four years has had only limited annual revenues for most of the years it
has been operating. The Company sustained operating losses for each of its fiscal years and has sustained significant accumulated operating
losses. The continued operation of the Company will be dependent upon its ability to generate operating revenues and to procure additional
financing. Based upon current plans to introduce HealthTab™ into new markets in Canada and internationally, maintain the Company’s
public listing on the TSX-Venture Exchange (the “ Exchange”) and support the continued registration of its securities in the
US, the Company may incur operating losses in future periods. These losses will occur because there are continuing expenses associated
with the roll out of the Company’s HealthTab™ network, legal and accounting fees, the maintenance of its public listing and
other expenses associated with running an operating business. Even if the Company becomes operationally profitable, the Company will
need to raise significant amounts of new funding to expand these activities. Also, the Company may not be successful in generating significant
revenues in the future. At the time of this report, the Company has sufficient funds to continue the roll out of its HealthTab™
network but it may be unable to do so without securing further financing. The Company may not be successful in generating revenues or
raising capital in the future. Failure to generate revenues or raise capital could cause the Company to cease operations.

If